Author Correction: A diverse landscape of FGFR alterations and co-mutations suggests potential therapeutic strategies in pediatric low-grade gliomas.
Saved in:
| Title: | Author Correction: A diverse landscape of FGFR alterations and co-mutations suggests potential therapeutic strategies in pediatric low-grade gliomas. |
|---|---|
| Authors: | Apfelbaum AA; Department of Pediatric Oncology, Dana-Farber Cancer/Boston Children's Cancer and Blood Disorders Center, Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Department of Pediatrics, Harvard Medical School, Harvard University, Boston, MA, USA., Morin E; Department of Pediatric Oncology, Dana-Farber Cancer/Boston Children's Cancer and Blood Disorders Center, Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Department of Pediatrics, Harvard Medical School, Harvard University, Boston, MA, USA.; Department of Women's and Children's Health, Uppsala University, Uppsala, Sweden.; Uppsala University Children's Hospital, Uppsala, Sweden., Sturm D; Division of Pediatric Glioma Research, Hopp Children's Cancer Center Heidelberg (KiTZ), Heidelberg, Germany.; National Center for Tumor Diseases (NCT), NCT Heidelberg, a partnership between DKFZ and Heidelberg University Hospital, Heidelberg, Germany.; German Cancer Research Center (DKFZ), Heidelberg, Germany.; Department of Pediatric Oncology, Hematology, Immunology, and Pulmonology, Heidelberg University Hospital, Heidelberg, Germany., Ayoub G; Department of Pathology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA., DiGiacomo J; Department of Pediatric Oncology, Dana-Farber Cancer/Boston Children's Cancer and Blood Disorders Center, Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Bahadur S; Department of Pediatric Oncology, Dana-Farber Cancer/Boston Children's Cancer and Blood Disorders Center, Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Chandarana B; Lady Davis Research Institute, Jewish General Hospital, Montreal, QC, Canada.; Department of Human Genetics, McGill University, Montreal, QC, Canada., Power PC; Department of Pediatric Oncology, Dana-Farber Cancer/Boston Children's Cancer and Blood Disorders Center, Boston, MA, USA.; Department of Pediatrics, Harvard Medical School, Harvard University, Boston, MA, USA., Cusick MM; Department of Pediatric Oncology, Dana-Farber Cancer/Boston Children's Cancer and Blood Disorders Center, Boston, MA, USA., Novikov D; Department of Pediatric Oncology, Dana-Farber Cancer/Boston Children's Cancer and Blood Disorders Center, Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Prabhakar P; Department of Pathology, Dana-Farber Cancer Institute, Boston, MA, USA., Jones RE; Department of Pathology, Dana-Farber Cancer Institute, Boston, MA, USA., Vogelzang J; Department of Pathology, Dana-Farber Cancer Institute, Boston, MA, USA., Bossi CC; Department of Pathology, Dana-Farber Cancer Institute, Boston, MA, USA., Malinowski S; Department of Pathology, Dana-Farber Cancer Institute, Boston, MA, USA., Woodward LM; Blizard Institute, Queen Mary University of London, London, UK., Jones TA; Blizard Institute, Queen Mary University of London, London, UK., Jeang J; Department of Pediatric Oncology, Dana-Farber Cancer/Boston Children's Cancer and Blood Disorders Center, Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Lamson SW; Department of Pediatric Oncology, Dana-Farber Cancer/Boston Children's Cancer and Blood Disorders Center, Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Collins J; Department of Pediatric Oncology, Dana-Farber Cancer/Boston Children's Cancer and Blood Disorders Center, Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Cai KY; Department of Pediatric Oncology, Dana-Farber Cancer/Boston Children's Cancer and Blood Disorders Center, Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Jones JS; Department of Pathology, Dana-Farber Cancer Institute, Boston, MA, USA., Oh S; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA., Jeon H; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA, USA., Wang J; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA, USA., Cameron A; Lurie Family Imaging Center, Center for Biomedical Imaging in Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Rechter P; Lurie Family Imaging Center, Center for Biomedical Imaging in Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., De Leon A; Department of Pediatric Oncology, Dana-Farber Cancer/Boston Children's Cancer and Blood Disorders Center, Boston, MA, USA., Murugesan K; Computational Discovery, Foundation Medicine Inc, Boston, MA, USA., Montesion M; Computational Discovery, Foundation Medicine Inc, Boston, MA, USA., Albacker LA; Computational Discovery, Foundation Medicine Inc, Boston, MA, USA., Ramkissoon SH; Pathology, Foundation Medicine Inc, Boston, MA, USA.; Labcorp Oncology, Durham, NC, USA.; Wake Forest Comprehensive Cancer Center and Department of Pathology, Winston-, Salem, NC, USA., van Tilburg CM; National Center for Tumor Diseases (NCT), NCT Heidelberg, a partnership between DKFZ and Heidelberg University Hospital, Heidelberg, Germany.; Department of Pediatric Oncology, Hematology, Immunology, and Pulmonology, Heidelberg University Hospital, Heidelberg, Germany.; Hopp Children's Cancer Center Heidelberg (KiTZ), Heidelberg, Germany.; Clinical Cooperation Unit Pediatric Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany., Hardin EC; National Center for Tumor Diseases (NCT), NCT Heidelberg, a partnership between DKFZ and Heidelberg University Hospital, Heidelberg, Germany.; Department of Pediatric Oncology, Hematology, Immunology, and Pulmonology, Heidelberg University Hospital, Heidelberg, Germany.; Hopp Children's Cancer Center Heidelberg (KiTZ), Heidelberg, Germany.; Clinical Cooperation Unit Pediatric Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany., Sievers P; Hopp Children's Cancer Center Heidelberg (KiTZ), Heidelberg, Germany.; Department of Neuropathology, University Hospital Heidelberg, Heidelberg, Germany.; CCU Neuropathology, German Consortium for Translational Cancer Research, Heidelberg, Germany, Heidelberg, Germany., Sahm F; German Cancer Research Center (DKFZ), Heidelberg, Germany.; Hopp Children's Cancer Center Heidelberg (KiTZ), Heidelberg, Germany.; Department of Neuropathology, University Hospital Heidelberg, Heidelberg, Germany.; CCU Neuropathology, German Consortium for Translational Cancer Research, Heidelberg, Germany, Heidelberg, Germany., Yeo KK; Department of Pediatric Oncology, Dana-Farber Cancer/Boston Children's Cancer and Blood Disorders Center, Boston, MA, USA.; Department of Pediatrics, Harvard Medical School, Harvard University, Boston, MA, USA., Rosenberg T; Department of Pediatric Oncology, Dana-Farber Cancer/Boston Children's Cancer and Blood Disorders Center, Boston, MA, USA.; Department of Pediatrics, Harvard Medical School, Harvard University, Boston, MA, USA., Chi SN; Department of Pediatric Oncology, Dana-Farber Cancer/Boston Children's Cancer and Blood Disorders Center, Boston, MA, USA.; Department of Pediatrics, Harvard Medical School, Harvard University, Boston, MA, USA., Wright KD; Department of Pediatric Oncology, Dana-Farber Cancer/Boston Children's Cancer and Blood Disorders Center, Boston, MA, USA.; Department of Pediatrics, Harvard Medical School, Harvard University, Boston, MA, USA., Hébert S; Lady Davis Research Institute, Jewish General Hospital, Montreal, QC, Canada., Peck S; Orlando Health- Arnold Palmer Hospital for Children, Orlando, FL, USA., Picca A; Sorbonne Université, Inserm, CNRS, UMR S 1127, Institut du Cerveau - Paris Brain Institute (ICM), AP-HP, Pitié Salpêtrière University Hospital, Paris, France., Larouche V; Department of Pediatrics, Hemato-Oncology, CHU de Québec-Université Laval, Quebec City, QC, Canada., Renzi S; Division of Pediatric Hematology-Oncology, Chul-Québec, Quebec City, QC, Canada., Buhrlage SJ; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA, USA., Bale TA; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Smith AA; Orlando Health- Arnold Palmer Hospital for Children, Orlando, FL, USA., Touat M; Sorbonne Université, Inserm, CNRS, UMR S 1127, Institut du Cerveau - Paris Brain Institute (ICM), AP-HP, Pitié Salpêtrière University Hospital, Paris, France., Jabado N; Department of Human Genetics, McGill University, Montreal, QC, Canada., Fischer ES; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA, USA., Eck MJ; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA, USA., Baird L; Department of Pediatric Oncology, Dana-Farber Cancer/Boston Children's Cancer and Blood Disorders Center, Boston, MA, USA.; Department of Pediatrics, Harvard Medical School, Harvard University, Boston, MA, USA.; Department of Neurosurgery, Harvard Medical School, Harvard University, Boston, MA, USA., Witt O; National Center for Tumor Diseases (NCT), NCT Heidelberg, a partnership between DKFZ and Heidelberg University Hospital, Heidelberg, Germany.; German Cancer Research Center (DKFZ), Heidelberg, Germany.; Department of Pediatric Oncology, Hematology, Immunology, and Pulmonology, Heidelberg University Hospital, Heidelberg, Germany.; Hopp Children's Cancer Center Heidelberg (KiTZ), Heidelberg, Germany.; Clinical Cooperation Unit Pediatric Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany., Kleinman CL; Lady Davis Research Institute, Jewish General Hospital, Montreal, QC, Canada.; Department of Human Genetics, McGill University, Montreal, QC, Canada., Nguyen QD; Lurie Family Imaging Center, Center for Biomedical Imaging in Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Sheer D; Blizard Institute, Queen Mary University of London, London, UK., Alexandrescu S; Department of Pediatric Oncology, Dana-Farber Cancer/Boston Children's Cancer and Blood Disorders Center, Boston, MA, USA.; Department of Pathology, Boston Children's Hospital, Harvard University, Boston, MA, USA., Jones DTW; Division of Pediatric Glioma Research, Hopp Children's Cancer Center Heidelberg (KiTZ), Heidelberg, Germany.; National Center for Tumor Diseases (NCT), NCT Heidelberg, a partnership between DKFZ and Heidelberg University Hospital, Heidelberg, Germany.; German Cancer Research Center (DKFZ), Heidelberg, Germany., Ligon KL; Broad Institute of MIT and Harvard, Cambridge, MA, USA. keith_ligon@dfci.harvard.edu.; Department of Pathology, Dana-Farber Cancer Institute, Boston, MA, USA. keith_ligon@dfci.harvard.edu.; Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA. keith_ligon@dfci.harvard.edu.; Department of Pathology, Boston Children's Hospital, Harvard University, Boston, MA, USA. keith_ligon@dfci.harvard.edu., Bandopadhayay P; Department of Pediatric Oncology, Dana-Farber Cancer/Boston Children's Cancer and Blood Disorders Center, Boston, MA, USA. Pratiti_Bandopadhayay@dfci.harvard.edu.; Broad Institute of MIT and Harvard, Cambridge, MA, USA. Pratiti_Bandopadhayay@dfci.harvard.edu.; Department of Pediatrics, Harvard Medical School, Harvard University, Boston, MA, USA. Pratiti_Bandopadhayay@dfci.harvard.edu. |
| Source: | Nature communications [Nat Commun] 2025 Oct 09; Vol. 16 (1), pp. 8970. Date of Electronic Publication: 2025 Oct 09. |
| Publication Type: | Published Erratum |
| Journal Info: | Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE; In Process |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2041-1723 |
|---|---|
| DOI: | 10.1038/s41467-025-64919-5 |
